Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 6 | 148200156 | regulatory region variant | C/T | snv | 0.40 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 6 | 148226666 | regulatory region variant | G/A | snv | 3.1E-02 |
|
0.800 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
1.000 | 6 | 148226666 | regulatory region variant | G/A | snv | 3.1E-02 |
|
0.800 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
1.000 | 6 | 148226666 | regulatory region variant | G/A | snv | 3.1E-02 |
|
0.800 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
1.000 | 6 | 148226666 | regulatory region variant | G/A | snv | 3.1E-02 |
|
0.800 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
1.000 | 0.040 | 6 | 148477321 | intron variant | A/G | snv | 4.4E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 148473896 | intron variant | C/A;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 148498580 | intron variant | C/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 148466023 | intron variant | C/T | snv | 4.5E-02 |
|
Wounds and Injuries | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 6 | 148488795 | intron variant | T/C | snv | 0.17 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 148491064 | intron variant | T/C | snv | 6.4E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 148487276 | intron variant | G/A | snv | 0.72 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 148484997 | intron variant | T/C | snv | 6.7E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.040 | 6 | 148193165 | regulatory region variant | G/T | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.040 | 6 | 148193165 | regulatory region variant | G/T | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.040 | 6 | 148193165 | regulatory region variant | G/T | snv | 0.33 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.040 | 6 | 148193165 | regulatory region variant | G/T | snv | 0.33 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.040 | 6 | 148193165 | regulatory region variant | G/T | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
6 | 148466870 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2008 | 2008 | |||||||||||
|
1.000 | 0.120 | 6 | 148383818 | intron variant | G/A | snv | 0.36 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 6 | 148481590 | intron variant | T/G | snv | 9.4E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 148482414 | intron variant | G/T | snv | 0.74 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 148478976 | non coding transcript exon variant | A/T | snv | 0.32 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 148200156 | regulatory region variant | C/T | snv | 0.40 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.040 | 6 | 148200156 | regulatory region variant | C/T | snv | 0.40 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 |